Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 3 » Issue 6
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4182)
- Volume 20, 2024 (76)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 3, 2007
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
Andreas Rogalewski, Jörg Kraus, Martin Hasselblatt, Christoffer Kraemer, Wolf-Rüdiger Schäbitz
Neuropsychiatric Disease and Treatment 2007, 3:987-991
Published Date: 15 January 2008
Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment
Léonie Jean, Martine Simard, Robert van Reekum, Marie-Ève Bergeron
Neuropsychiatric Disease and Treatment 2007, 3:975-985
Published Date: 15 January 2008
Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians
Adriana Foster, Zixuan Wang, Manzoor Usman, Edna Stirewalt, Peter Buckley
Neuropsychiatric Disease and Treatment 2007, 3:965-973
Published Date: 15 January 2008
Early rising children are more active than late risers
Jun Kohyama
Neuropsychiatric Disease and Treatment 2007, 3:959-963
Published Date: 15 January 2008
Cognitive decline tracks motor progression and not disease duration in Parkinson patients
BD Riggeal, GP Crucian, P Seignourel, CE Jacobson IV, MS Okun, et al
Neuropsychiatric Disease and Treatment 2007, 3:955-958
Published Date: 15 January 2008
Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder
Antigone S Papavasiliou, Irene Nikaina, Ioanna Rizou, Stratos Alexandrou
Neuropsychiatric Disease and Treatment 2007, 3:949-954
Published Date: 15 January 2008
Rivastigmine in Chinese patients with subcortical vascular dementia
Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam, et al
Neuropsychiatric Disease and Treatment 2007, 3:943-948
Published Date: 15 January 2008
Urban–rural differences in pediatric traumatic head injuries: A prospective nationwide study
Jonas G Halldorsson, Kjell M Flekkoy, Kristinn R Gudmundsson, Gudmundur B Arnkelsson, Eirikur Orn Arnarson
Neuropsychiatric Disease and Treatment 2007, 3:935-941
Published Date: 15 January 2008
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions
Winnie W Leung, Margaret M McClure, Larry J Siever, Deanna M Barch, Philip D Harvey
Neuropsychiatric Disease and Treatment 2007, 3:925-934
Published Date: 15 January 2008
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
Gaby Abraham, Roumen Milev, Lauren Lazowski, Ruzica Jokic, Regina du Toit, et al
Neuropsychiatric Disease and Treatment 2007, 3:919-924
Published Date: 15 January 2008
Rule knowledge aids performance on spatial and object alternation tasks by alcoholic patients with and without Korsakoff’s amnesia
Fiona J Bardenhagen, Marlene Oscar-Berman, Stephen C Bowden
Neuropsychiatric Disease and Treatment 2007, 3:907-918
Published Date: 15 January 2008
The patients’ perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD
Irene Hegeman Richard, Kori A LaDonna, Rosanne Hartman, Carol Podgorski, Roger Kurlan, et al
Neuropsychiatric Disease and Treatment 2007, 3:903-906
Published Date: 15 January 2008
Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients
Katia M’Bailara, Donatienne Van den Bulke, Nicolas Demazeau, Jacques Demotes-Mainard, Chantal Henry
Neuropsychiatric Disease and Treatment 2007, 3:899-902
Published Date: 15 January 2008
What is the impact of physician communication and patient understanding in the management of headache?
Meenal Patwardhan, Remy R Coeytaux, Rajeshwari Deshmukh, Gregory Samsa
Neuropsychiatric Disease and Treatment 2007, 3:893-897
Published Date: 15 January 2008
Clinical use of pregabalin in the management of central neuropathic pain
Nanna B Finnerup, Troels S Jensen
Neuropsychiatric Disease and Treatment 2007, 3:885-891
Published Date: 15 January 2008
Paliperidone ER: a review of the clinical trial data
Philip G Janicak, Elizabeth A Winans
Neuropsychiatric Disease and Treatment 2007, 3:869-883
Published Date: 15 January 2008
A review of quetiapine in combination with antidepressant therapy in patients with depression
Ella J Daly, Madhukar H Trivedi
Neuropsychiatric Disease and Treatment 2007, 3:855-867
Published Date: 15 January 2008
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Prashant Gajwani, David J Muzina, David E Kemp, Keming Gao, Joseph R Calabrese
Neuropsychiatric Disease and Treatment 2007, 3:847-853
Published Date: 15 January 2008
Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
Steven C Stoner, Megan M Dahmen
Neuropsychiatric Disease and Treatment 2007, 3:839-846
Published Date: 15 January 2008
The therapeutic potential of escitalopram in the treatment of panic disorder
Mark H Townsend, Erich J Conrad
Neuropsychiatric Disease and Treatment 2007, 3:835-838
Published Date: 15 January 2008
Ziprasidone in the treatment of mania in bipolar disorder
Stephen E Nicolson, Charles B Nemeroff
Neuropsychiatric Disease and Treatment 2007, 3:823-834
Published Date: 15 January 2008
Topiramate in the treatment of partial and generalized epilepsy
Edward Faught
Neuropsychiatric Disease and Treatment 2007, 3:811-821
Published Date: 15 January 2008
Almotriptan in the treatment of migraine
Giorgio Sandrini, Armando Perrotta, Natalia L Arce Leal, Simona Buscone, Giuseppe Nappi
Neuropsychiatric Disease and Treatment 2007, 3:799-809
Published Date: 15 January 2008
Neurologic uses of botulinum neurotoxin type A
John P Ney, Kevin R Joseph
Neuropsychiatric Disease and Treatment 2007, 3:785-798
Published Date: 15 January 2008
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
Jennifer L Reingold, John C Morgan, Kapil D Sethi
Neuropsychiatric Disease and Treatment 2007, 3:775-783
Published Date: 15 January 2008
Indiplon in the treatment of sleep disorders
Alan Lankford
Neuropsychiatric Disease and Treatment 2007, 3:765-773
Published Date: 15 January 2008
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Stefan Evers
Neuropsychiatric Disease and Treatment 2007, 3:761-764
Published Date: 15 January 2008
Adult neural stem cells: The promise of the future
Philippe Taupin
Neuropsychiatric Disease and Treatment 2007, 3:753-760
Published Date: 15 January 2008
A review on primary progressive aphasia
Gabriel C Léger, Nancy Johnson
Neuropsychiatric Disease and Treatment 2007, 3:745-752
Published Date: 15 January 2008
Sleep disturbances and suicide risk: A review of the literature
Rebecca A Bernert, Thomas E Joiner
Neuropsychiatric Disease and Treatment 2007, 3:735-743
Published Date: 15 January 2008
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
Stéphane Auvin
Neuropsychiatric Disease and Treatment 2007, 3:729-734
Published Date: 15 January 2008
Management of epilepsy in the elderly
Juan José Poza
Neuropsychiatric Disease and Treatment 2007, 3:723-728
Published Date: 15 January 2008
Role of endocannabinoids in regulating drug dependence
Daniela Parolaro, Daniela Vigano’, Natalia Realini, Tiziana Rubino
Neuropsychiatric Disease and Treatment 2007, 3:711-721
Published Date: 15 January 2008
Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
Christopher L Edwards, Renee Dunn Raynor, Miriam Feliu, Camela McDougald, Stephanie Johnson, et al
Neuropsychiatric Disease and Treatment 2007, 3:705-709
Published Date: 15 January 2008
Editorial: Botulinum toxin – From WMD to therapeutic agent and cosmetic aid ||Free Paper||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2007, 3:703-704
Published Date: 15 January 2008